Acceptance and perceived efficacy of intraoral versus extraoral photobiomodulation for oral mucositis prevention in pediatric patients.
Support Care CancerSep 23, 2026 (epub)
Isabela de Oliveira Plugge Freitas, Giovanna Leal Klein Renz, Isabela Schuartz et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the acceptance and perceived efficacy of intraoral (IO) versus extraoral (EO) photobiomodulation therapy for preventing oral mucositis in 32 pediatric oncology patients. Results indicated that 65.6% of caregivers preferred EO-PBMT due to greater comfort, with significantly less discomfort reported during EO-PBMT (6.3%) compared to IO-PBMT (43.8%, p = 0.001).
Key findings
- 65.6% of caregivers preferred EO-PBMT over IO-PBMT.
- 43.8% reported discomfort during IO-PBMT compared to 6.3% during EO-PBMT.
- 34.4% perceived IO-PBMT as providing better pain control, while 12.5% favored EO-PBMT.
Why it matters
Understanding caregiver preferences and perceived efficacy of treatment modalities is crucial in pediatric oncology, as it can influence adherence to supportive care strategies and overall patient comfort during chemotherapy.